If you liked this article you might like

Akebia Secures Exclusive Access to U.S. Dialysis Patients With Vifor-Fresenius Pact
Group Stink; Good, the Bad and the Ugly: Doug Kass' Views
Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views
Akebia Surges but is Still Undervalued, Making Takeover a Potential Remedy